Thomas Charles Heineman
CIK: 0002103579
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ONCY
ONCOLYTICS BIOTECH INC
Officer
Discretionary Trading P&L
Holdings
About Heineman Thomas Charles
Heineman Thomas Charles (SEC CIK 0002103579) files insider reports with the SEC as Chief Medical Officer of ONCOLYTICS BIOTECH INC (ONCY).
Signal8 holds 3 ownership filings by Heineman Thomas Charles (1 Form 3, 2 Form 4), filed between Jan 2, 2026 and Jun 3, 2026. Those filings report 2 transactions, from Feb 12, 2026 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Heineman Thomas Charles's filings is in SAN DIEGO, CA.
Recent filings by Heineman Thomas Charles
Other insiders filing for ONCOLYTICS BIOTECH INC (ONCY)
- McAdory John Bearden, Chief Operating Officer
- Pisano Wayne, Director
- RIGBY JONATHAN, Director
- Holtham Angela, Director
- Parsons James T., Director
- Look Kirk, Chief Financial Officer